Antibiotics and hormones have been used prophylactically for growth and disease reduction in the majority of food animals worldwide. However, there is now great pressure on farmers to eliminate these drugs while maintaining current production levels.
FPS-4, a product platform consisting of a patented collection of anaerobic bacteria isolates from the Faecalibacterium Prausnitzii bacteria species, is being developed to provide groundbreaking alternatives for food animal productivity and health. The objectives of this study were to evaluate the effects of administering products developed from FPS-4 to examine the benefits for newborn dairy calves on subsequent growth, health, and fecal microbiome.
This placebo-controlled trial published by researchers at Cornell’s College of Veterinary Medicine found that calves treated with our proprietary collection of “super-probiotic” isolates demonstrated significant increases in growth, reduction in scours, and lowered mortality when administered to newborn calves.
"As of Jan 1st, 2017', it is illegal to use medically important antibiotics for production purposes, and animal producers will need to obtain authorization from a licensed veterinarian to use them for prevention, control or treatment of a specifically identified disease."
~ U.S. Food and Drug AdministrationPUBLICATION TITLE: Oral Administration of Faecalibacterium Prausnitzii Decreased the Incidence of Severe Diarrhea and Related Mortality Rate and Increased Weight Gain in Preweaned Dairy Heifers
